Peripheral Neuropathy Evaluations of Patients With Prolonged Long COVID.
Anne Louise OaklanderAlexander J MillsMary KelleyLisa S ToranBryan SmithMarinos C DalakasAvindra NathPublished in: Neurology(R) neuroimmunology & neuroinflammation (2022)
Among evaluated patients with long COVID, prolonged, often disabling, small-fiber neuropathy after mild SARS-CoV-2 was most common, beginning within 1 month of COVID-19 onset. Various evidence suggested infection-triggered immune dysregulation as a common mechanism.